Surgical Science Sweden AB (FRA:4P41) EPS (Basic): €0.10 (TTM As of Mar. 2026)


FRA:4P41 Surgical Science Sweden AB FRA:4P41
86 GF Score
Price €2.72
GF Value €13.83
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB EPS (Basic)?

Surgical Science Sweden AB FRA:4P41 -3.89% 86 EPS (Basic) is €0.10 as of Mar. 2026. GuruFocus rates FRA:4P41 with a GF Score™ of 86/100 and a GF Value™ of €13.83 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Surgical Science Sweden AB's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €0.03. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.10.

Surgical Science Sweden AB's EPS (Diluted) for the three months ended in Mar. 2026 was €0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.10.

Surgical Science Sweden AB's EPS without NRI for the three months ended in Mar. 2026 was €0.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.10.

During the past 12 months, Surgical Science Sweden AB's average EPS without NRIGrowth Rate was -62.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -29.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 19.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Surgical Science Sweden AB's highest 3-Year average EPS without NRI Growth Rate was 116.90% per year. The lowest was -29.20% per year. And the median was 23.60% per year.

Surgical Science Sweden AB  (FRA:4P41) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Surgical Science Sweden AB EPS (Basic) Related Terms

Surgical Science Sweden AB EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Surgical Science Sweden AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgical Science Sweden AB EPS (Basic) Chart

Surgical Science Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.34 0.41 0.22 0.12

Surgical Science Sweden AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 -0.04 0.04 0.06 0.03
FRA:4P41
86GF Score
Surgical Science Sweden AB FRA:4P41
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Surgical Science Sweden AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Surgical Science Sweden AB's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(6.14-0)/51.026
=0.12

Surgical Science Sweden AB's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1.729-0)/51.026
=0.03

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €0.10 mean?
Surgical Science Sweden AB (FRA:4P41) has a EPS (Basic) of €0.10 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Surgical Science Sweden AB and its competitors.
Is Surgical Science Sweden AB's EPS (Basic) too high?
Surgical Science Sweden AB's current EPS (Basic) is €0.10. Overall, Surgical Science Sweden AB has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's EPS (Basic) compare to VEEV and BTSG?
Surgical Science Sweden AB's EPS (Basic) of €0.10 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Surgical Science Sweden AB and its competitors. Surgical Science Sweden AB's current EPS (Basic) is €0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (FRA:4P41) is currently considered Significantly Undervalued. The stock's GF Value™ is €13.83, compared to a current price of €2.72 — trading 80.3% below its estimated fair value. The current EPS (Basic) is €0.10. Surgical Science Sweden AB's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Surgical Science Sweden AB (FRA:4P41), the current EPS (Basic) is €0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgical Science Sweden AB (FRA:4P41) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of €2.72 is trading 80.3% below its estimated GF Value™ of €13.83. GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.

Key valuation signals for FRA:4P41:

  • EPS (Basic): €0.10
  • GF Value™: €13.83 vs. price of €2.72 (80.3% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the FRA:4P41 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Surgical Science Sweden AB Business Description

Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
86GF Score

Get the complete analysis for FRA:4P41

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.72
Price
€13.83
GF Value